Cargando…
Urolastic—A New Bulking Agent for the Treatment of Women with Stress Urinary Incontinence: Outcome of 12 Months Follow Up
Objective. To evaluate the efficacy and safety of the new injectable implant, Urolastic, in women with stress urinary incontinence (SUI) after 12-month followup. Materials and Methods. A prospective, cohort study included adult women with SUI. Patients were treated with Urolastic periurethral inject...
Autores principales: | Zajda, Janusz, Farag, Fawzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881341/ https://www.ncbi.nlm.nih.gov/pubmed/24454351 http://dx.doi.org/10.1155/2013/724082 |
Ejemplares similares
-
Urolastic for the treatment of women with stress urinary incontinence: 24-month follow-up
por: Zajda, Janusz, et al.
Publicado: (2015) -
Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross‐sectional study
por: Casteleijn, Fenne M., et al.
Publicado: (2020) -
An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation
por: Futyma, Konrad, et al.
Publicado: (2015) -
Bulking agents for urinary incontinence: what, when and where?
por: Kasyan, George, et al.
Publicado: (2015) -
Combination therapy with botulinum toxin and bulking agent—An efficient, sustainable, and safe method to treat elderly women with mixed urinary incontinence
por: Viereck, Volker, et al.
Publicado: (2021)